granisetron and Dyskinesia, Drug-Induced

granisetron has been researched along with Dyskinesia, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bédard, D; Frouni, I; Hamadjida, A; Huot, P; Kwan, C1
Alberts, VA; Catalano, G; Poole, MA1

Other Studies

2 other study(ies) available for granisetron and Dyskinesia, Drug-Induced

ArticleYear
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat.
    Behavioural pharmacology, 2021, 02-01, Volume: 32, Issue:1

    Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Granisetron; Levodopa; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists

2021
Tardive dyskinesia as a result of long-term prochlorperazine use.
    Southern medical journal, 1996, Volume: 89, Issue:10

    Topics: Antiemetics; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Prochlorperazine; Time Factors; Vomiting

1996